From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors - Top-Institutions - MDSpire

Utilizing Patient-Derived Tumor Organoids for Tailored Cancer Treatment: Progress in Managing Advanced Solid Tumors

  • By

  • Gang Wang

  • Zhibin Tan

  • Wenting Jia

  • Yuanyuan Liu

  • Huan Wang

  • Wenbo Sun

  • Weiwei Sun

  • Lu Meng

  • Yudong Zhang

  • Ning Liu

  • Feng Li

  • Hongchao Dong

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    North China University of Science and Technology Affiliated Hospital
    North China University of Science and Technology Affiliated Hospital

    Tangshan, Hebei

    Key Differentiators

    • Oncology

  • #2

    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego
    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego

    La Jolla, California

    Key Differentiators

    • Oncology

  • #3

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

  • #4

    Sun Yat-Sen University Cancer Center
    Sun Yat-Sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Oncology

  • #5

    University of Massachusetts Amherst
    University of Massachusetts Amherst

    Amherst, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors

  • by Gang Wang, Zhibin Tan, Wenting Jia, Yuanyuan Liu, Huan Wang, Wenbo Sun, Weiwei Sun, Lu Meng, Yudong Zhang, Ning Liu, Feng Li, Hongchao Dong

  • July 20, 2026

Related Content

Prognostic value of existing scoring systems for early mortality in phase I immunotherapy trials: a head-to-head real-world cohort study

Impact of multi-channel follow-up as continuous nursing on cancer pain control, adverse reactions, and quality of life in patients with digestive tract tumors: a controlled study of 136 cases

Treatment patterns and survival outcomes in elderly patients with intrahepatic cholangiocarcinoma: NCDB analysis